BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24910369)

  • 41. CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages.
    Papin A; Tessoulin B; Bellanger C; Moreau A; Le Bris Y; Maisonneuve H; Moreau P; Touzeau C; Amiot M; Pellat-Deceunynck C; Le Gouill S; Chiron D
    Leukemia; 2019 Oct; 33(10):2442-2453. PubMed ID: 30940906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2017 Aug; 92(8):806-813. PubMed ID: 28699667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
    Geisler CH; Kolstad A; Laurell A; Jerkeman M; Räty R; Andersen NS; Pedersen LB; Eriksson M; Nordström M; Kimby E; Bentzen H; Kuittinen O; Lauritzsen GF; Nilsson-Ehle H; Ralfkiaer E; Ehinger M; Sundström C; Delabie J; Karjalainen-Lindsberg ML; Brown P; Elonen E;
    Br J Haematol; 2012 Aug; 158(3):355-62. PubMed ID: 22640180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma.
    Xu DM; Liang JH; Wang L; Zhu HY; Xia Y; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1003-1009. PubMed ID: 31915915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era.
    Aoki K; Tabata S; Yonetani N; Matsushita A; Ishikawa T
    Acta Haematol; 2013; 130(4):242-6. PubMed ID: 23860478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database.
    Salek D; Vesela P; Boudova L; Janikova A; Klener P; Vokurka S; Jankovska M; Pytlik R; Belada D; Pirnos J; Moulis M; Kodet R; Michal M; Janousova E; Muzik J; Mayer J; Trněný M
    Leuk Lymphoma; 2014 Apr; 55(4):802-10. PubMed ID: 23772666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
    Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.
    Aukema SM; Hoster E; Rosenwald A; Canoni D; Delfau-Larue MH; Rymkiewicz G; Thorns C; Hartmann S; Kluin-Nelemans H; Hermine O; Dreyling M; Klapper W
    Blood; 2018 Jan; 131(4):417-420. PubMed ID: 29196411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel clinical immune-related prognostic model predicts the overall survival of mantle cell lymphoma.
    Lv H; Fei Y; Li W; Wang Y; Wang J; He J; Liu X; Li L; Qiu L; Qian Z; Zhou S; Meng B; Zhai Q; Ren X; Zou D; Cai Q; Wang X; Zhang H
    Hematol Oncol; 2022 Aug; 40(3):343-355. PubMed ID: 35368100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.
    Shabo I; Stål O; Olsson H; Doré S; Svanvik J
    Int J Cancer; 2008 Aug; 123(4):780-6. PubMed ID: 18506688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
    Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
    Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma.
    Miao Y; Zhou XH; Guo JJ; Sun Q; Shi K; Wu JZ; Zhu HY; Wang L; Fan L; Xu W; Li JY
    Cancer Med; 2019 Jun; 8(6):2751-2758. PubMed ID: 30980510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
    Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
    Front Immunol; 2021; 12():724429. PubMed ID: 34512652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
    Koh YW; Park C; Yoon DH; Suh C; Huh J
    Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
    Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.